Correlation between the Efficacy of Lamotrigine and the Serum Lamotrigine Level during the Remission Phase of Acute Bipolar II Depression: A Naturalistic and Unblinded Prospective Pilot Study-Reference-Cited by-同舟云学术

Correlation between the Efficacy of Lamotrigine and the Serum Lamotrigine Level during the Remission Phase of Acute Bipolar II Depression: A Naturalistic and Unblinded Prospective Pilot Study

Published:2017 Issue:4 Volume:40 Page:413-418
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Kikkawa Akiyoshi¹²,Kitamura Yoshihisa¹,Aiba Tetsuya³,Hiraki Koichi²,Sendo Toshiaki¹

Affiliation:

1. Department of Clinical Pharmacy, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University

2. Department of Pharmacy, Hiroshima City Hospital

3. Department of Clinical Pharmacokinetics and Therapeutics, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/40/4/40_b16-00725/_pdf

Reference31 articles.

1. 1) Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J. Affect. Disord., 73, 123–131 (2003).

2. 2) Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch. Gen. Psychiatry, 60, 261–269 (2003).

3. 3) Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry, 62, 593–602 (2005).

4. 4) Kessler RC, Akiskal HS, Angst J, Guyer M, Hirschfeld RM, Merikangas KR, Stang PE. Validity of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0. J. Affect. Disord., 96, 259–269 (2006).

5. 5) Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J. Clin. Psychiatry, 60, 79–88 (1999).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes;Pharmaceuticals;2024-05-16

2. Factors associated with lamotrigine concentration/dose ratio in individuals with bipolar disorders;European Neuropsychopharmacology;2023-08

3. Glial Cell-Targeted Treatments for Bipolar Disorder: A Systematic Review of Available Data and Clinical Perspectives;Open Journal of Medical Psychology;2023

4. Integrated entitymetrics analysis for health information on bipolar disorder using social media data and scientific literature;Aslib Journal of Information Management;2022-08-22

5. Lamotrigine Extraction and Quantification by UPLC-DAD in Plasma from Patients with Bipolar Disorder;International Journal of Analytical Chemistry;2022-04-13